-
Je něco špatně v tomto záznamu ?
Regulatory T cells engineered with TCR signaling-responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter
SK. Eskandari, I. Sulkaj, MB. Melo, N. Li, H. Allos, JB. Alhaddad, B. Kollar, TJ. Borges, AS. Eskandari, MA. Zinter, S. Cai, JP. Assaker, JY. Choi, BS. Al Dulaijan, A. Mansouri, Y. Haik, BA. Tannous, WJ. van Son, HGD. Leuvenink, B. Pomahac, LV....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- Publikační typ
- časopisecké články MeSH
Adoptive cell transfer of ex vivo expanded regulatory T cells (Tregs) has shown immense potential in animal models of auto- and alloimmunity. However, the effective translation of such Treg therapies to the clinic has been slow. Because Treg homeostasis is known to require continuous T cell receptor (TCR) ligation and exogenous interleukin-2 (IL-2), some investigators have explored the use of low-dose IL-2 injections to increase endogenous Treg responses. Systemic IL-2 immunotherapy, however, can also lead to the activation of cytotoxic T lymphocytes and natural killer cells, causing adverse therapeutic outcomes. Here, we describe a drug delivery platform, which can be engineered to autostimulate Tregs with IL-2 in response to TCR-dependent activation, and thus activate these cells in sites of antigen encounter. To this end, protein nanogels (NGs) were synthesized with cleavable bis(N-hydroxysuccinimide) cross-linkers and IL-2/Fc fusion (IL-2) proteins to form particles that release IL-2 under reducing conditions, as found at the surface of T cells receiving stimulation through the TCR. Tregs surface-conjugated with IL-2 NGs were found to have preferential, allograft-protective effects relative to unmodified Tregs or Tregs stimulated with systemic IL-2. We demonstrate that murine and human NG-modified Tregs carrying an IL-2 cargo perform better than conventional Tregs in suppressing alloimmunity in murine and humanized mouse allotransplantation models. In all, the technology presented in this study has the potential to improve Treg transfer therapy by enabling the regulated spatiotemporal provision of IL-2 to antigen-primed Tregs.
Department of Electrical Engineering Delft University of Technology 2628 CD Delft Netherlands
Division of Plastic Surgery Brigham and Women's Hospital Harvard Medical School Boston MA 02115 USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21001321
- 003
- CZ-PrNML
- 005
- 20220106131903.0
- 007
- ta
- 008
- 210119s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1126/scitranslmed.aaw4744 $2 doi
- 035 __
- $a (PubMed)33177180
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Eskandari, Siawosh K $u Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Division of Nephrology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, Netherlands.
- 245 10
- $a Regulatory T cells engineered with TCR signaling-responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter / $c SK. Eskandari, I. Sulkaj, MB. Melo, N. Li, H. Allos, JB. Alhaddad, B. Kollar, TJ. Borges, AS. Eskandari, MA. Zinter, S. Cai, JP. Assaker, JY. Choi, BS. Al Dulaijan, A. Mansouri, Y. Haik, BA. Tannous, WJ. van Son, HGD. Leuvenink, B. Pomahac, LV. Riella, L. Tang, MAJ. Seelen, DJ. Irvine, JR. Azzi,
- 520 9_
- $a Adoptive cell transfer of ex vivo expanded regulatory T cells (Tregs) has shown immense potential in animal models of auto- and alloimmunity. However, the effective translation of such Treg therapies to the clinic has been slow. Because Treg homeostasis is known to require continuous T cell receptor (TCR) ligation and exogenous interleukin-2 (IL-2), some investigators have explored the use of low-dose IL-2 injections to increase endogenous Treg responses. Systemic IL-2 immunotherapy, however, can also lead to the activation of cytotoxic T lymphocytes and natural killer cells, causing adverse therapeutic outcomes. Here, we describe a drug delivery platform, which can be engineered to autostimulate Tregs with IL-2 in response to TCR-dependent activation, and thus activate these cells in sites of antigen encounter. To this end, protein nanogels (NGs) were synthesized with cleavable bis(N-hydroxysuccinimide) cross-linkers and IL-2/Fc fusion (IL-2) proteins to form particles that release IL-2 under reducing conditions, as found at the surface of T cells receiving stimulation through the TCR. Tregs surface-conjugated with IL-2 NGs were found to have preferential, allograft-protective effects relative to unmodified Tregs or Tregs stimulated with systemic IL-2. We demonstrate that murine and human NG-modified Tregs carrying an IL-2 cargo perform better than conventional Tregs in suppressing alloimmunity in murine and humanized mouse allotransplantation models. In all, the technology presented in this study has the potential to improve Treg transfer therapy by enabling the regulated spatiotemporal provision of IL-2 to antigen-primed Tregs.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sulkaj, Ina $u Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA. Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- 700 1_
- $a Melo, Mariane B $u Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA. Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- 700 1_
- $a Li, Na $u Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- 700 1_
- $a Allos, Hazim $u Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- 700 1_
- $a Alhaddad, Juliano B $u Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- 700 1_
- $a Kollar, Branislav $u Division of Plastic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- 700 1_
- $a Borges, Thiago J $u Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.
- 700 1_
- $a Eskandari, Arach S $u Department of Electrical Engineering, Delft University of Technology, 2628 CD Delft, Netherlands.
- 700 1_
- $a Zinter, Max A $u Experimental Therapeutics and Molecular Imaging Unit, Department of Neurology, Neuro-Oncology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA.
- 700 1_
- $a Cai, Songjie $u Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- 700 1_
- $a Assaker, Jean Pierre $u Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- 700 1_
- $a Choi, John Y $u Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- 700 1_
- $a Al Dulaijan, Basmah S $u Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- 700 1_
- $a Mansouri, Amr $u Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- 700 1_
- $a Haik, Yousef $u Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- 700 1_
- $a Tannous, Bakhos A $u Experimental Therapeutics and Molecular Imaging Unit, Department of Neurology, Neuro-Oncology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA.
- 700 1_
- $a van Son, Willem J $u Division of Nephrology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, Netherlands.
- 700 1_
- $a Leuvenink, Henri G D $u Department of Surgery, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, Netherlands.
- 700 1_
- $a Pomahač, Bohdan, $u Division of Plastic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. $d 1971- $7 xx0117402
- 700 1_
- $a Riella, Leonardo V $u Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.
- 700 1_
- $a Tang, Li $u Institute of Bioengineering, École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland. Institute of Materials Science and Engineering, École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
- 700 1_
- $a Seelen, Marc A J $u Division of Nephrology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, Netherlands.
- 700 1_
- $a Irvine, Darrell J $u Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA. djirvine@mit.edu jazzi@bwh.harvard.edu. Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA. Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
- 700 1_
- $a Azzi, Jamil R $u Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. djirvine@mit.edu jazzi@bwh.harvard.edu.
- 773 0_
- $w MED00177505 $t Science translational medicine $x 1946-6242 $g Roč. 12, č. 569 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33177180 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20210119 $b ABA008
- 991 __
- $a 20220106131900 $b ABA008
- 999 __
- $a ind $b bmc $g 1611142 $s 1121604
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 12 $c 569 $e 2020Nov11 $i 1946-6242 $m Science translational medicine $n Sci Transl Med $x MED00177505
- LZP __
- $a Pubmed-20210119
